Horizon Therapeutics Public (NASDAQ:HZNP) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) in a report published on Tuesday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Separately, Jefferies Financial Group lowered Horizon Therapeutics Public from a buy rating to a hold rating in a research report on Friday, September 1st. […]